|
|||||
|
|
Postmarketing re-evaluation of irinotecan plus 5-fluorouracil/leucovorin for first-line treatment of metastatic colorectal cancer |
|
| Authors: | Chico Isagani M Pazdur Richard |
| Affiliation: | Division of Oncologic Drug Products, Food and Drug Administration, Rockville, MD, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |